Gene · 8554
Papers1,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Establishing genome sequencing and assembly for non-model and emerging model organisms: a brief guide. | Front Zool | 2025 | 40247279 | PubTator, text mining | PubMed |
| Coinfection with bacterial pathogens and genetic modification of PRRSV-2 for suppression of NF-κB and attenuation of proinflammatory responses. | Virology | 2025 | 40086205 | PubTator, text mining | PubMed |
| A bioinformatics analysis of gene expression in endometrial cancer, endometriosis and obesity. | Women Health | 2025 | 39653677 | PubTator, text mining | PubMed |
| Correction: Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1. | Mol Cancer | 2024 | 39716144 | PubTator, text mining | PubMed |
| An integrated approach using proximity labelling and chemical crosslinking to probe in situ host-virus protein-protein interactions. | QRB Discov | 2024 | 39687228 | PubTator, text mining | PubMed |
| PIAS family gene expression: implications for prognosis, immunomodulation, and chemotherapy response. | Am J Transl Res | 2024 | 39678595 | PubTator, text mining | PubMed |
| ZNF350 gene polymorphisms promote the response to Peg-IFNα therapy through JAK-STAT signaling pathway in patients with chronic hepatitis B. | Front Immunol | 2024 | 39575240 | PubTator, text mining | PubMed |
| Computational insights into irinotecan's interaction with UBE2I in ovarian and endometrial cancers. | Comput Biol Chem | 2024 | 39476484 | PubTator, text mining | PubMed |
| Stepwise phosphorylation and SUMOylation of PIDD1 drive PIDDosome assembly in response to DNA repair failure. | Nat Commun | 2024 | 39448602 | PubTator, text mining | PubMed |
| Pharmacologic Induction of ERα SUMOylation Disrupts Its Chromatin Binding. | ACS Chem Biol | 2024 | 39432240 | PubTator, text mining | PubMed |
| The role of SUMOylation in biomolecular condensate dynamics and protein localization. | Cell Insight | 2024 | 39399482 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
| Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1. | Mol Cancer | 2024 | 39334380 | PubTator, text mining | PubMed |
| Cellular and molecular determinants of bacterial burden in leprosy granulomas revealed by single-cell multimodal omics. | EBioMedicine | 2024 | 39321499 | PubTator, text mining | PubMed |
| PIAS1 S510G variant acts as a genetic modifier of spinocerebellar ataxia type 3 by selectively impairing mutant ataxin-3 proteostasis. | Int J Biochem Cell Biol | 2024 | 39293559 | PubTator, text mining | PubMed |
| Identification of Biomarkers Associated With Paget's Disease of Bone and Bone Metastasis From Breast Cancer Patients. | Cancer Rep (Hoboken) | 2024 | 39233667 | PubTator, text mining | PubMed |
| GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity. | Oncogene | 2024 | 39068217 | PubTator, text mining | PubMed |
| The Role of Interferon Regulatory Factors in Liver Diseases. | Int J Mol Sci | 2024 | 38999981 | PubTator, text mining | PubMed |
| Unconventional posttranslational modification in innate immunity. | Cell Mol Life Sci | 2024 | 38970666 | PubTator, text mining | PubMed |
| A UL26-PIAS1 complex antagonizes anti-viral gene expression during Human Cytomegalovirus infection. | PLoS Pathog | 2024 | 38768227 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8554/papers?page=3